Dr. Rebecca Boswell, Director of Penn Medicine Princeton Center for Eating Disorders, shares her expert perspectives on how the rise in GLP-1 medication use is impacting the eating disorder community – and why clinicians should be paying attention.

Tags: princeton healthcare penn medicine, princeton healthcare, penn medicine, ozempic